Parkervision INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OQB
ParkerVision, Inc. reported a reduced net loss for the first half of 2026, but faces ongoing legal proceedings and a decrease in cash reserves.
OQB
ParkerVision, Inc. announced the retirement of director Lewis Titterton and the appointment of Anthony Bowers to the board, effective May 19, 2026.
OQB
ParkerVision announced its first quarter 2026 financial results, reporting a reduced net loss, while highlighting significant developments in its ongoing patent infringement litigation against major tech companies.
OQB
ParkerVision, Inc. has extended the expiration dates of stock options for its CEO and CFO to preserve long-term incentive value.
OQB
ParkerVision reported a reduced net loss for 2025, driven by changes in contingent payment obligations, while facing delays and appeals in key patent infringement lawsuits.
OQB
ParkerVision, Inc. converted $675,000 in outstanding convertible promissory notes and $13,200 in accrued interest into 3,277,099 shares of common stock at an exchange price of $0.21 per share.
OQB
ParkerVision, Inc. announced new performance-based and time-based stock options for its CEO and CFO, alongside a 2.5% salary increase.
OQB
ParkerVision, Inc. announced the closing of a $3.46 million common stock sale to accredited and institutional investors.
OQB
ParkerVision, Inc. entered into subscription agreements with accredited investors to sell 16.48 million shares of common stock for approximately $3.46 million in a direct offering.
OQB
ParkerVision, Inc. announced the sale of $1 million in common stock to independent director Lewis H. Titterton, Jr. at $0.21 per share.
OQB
ParkerVision, Inc. announced that director Lewis H. Titterton, Jr. will purchase 4,761,905 shares of common stock for $1 million at $0.21 per share.
OQB
ParkerVision reported a significantly reduced net loss in Q3 2025, driven by lower contingent payment obligation changes, while advancing critical patent infringement appeals and trials.
OQB
ParkerVision, Inc. announced the results of its Annual Meeting of Shareholders held on September 30, 2025, where directors were elected, the auditor was ratified, and executive compensation was approved.
OQB
ParkerVision, Inc. reported a significantly increased net loss for the second quarter of 2025, driven by higher operating expenses and ongoing complex patent litigation.
OQB
ParkerVision, Inc. announced that its Board of Directors approved an amendment to its 2019 Long-Term Incentive Plan, increasing the share reserve for equity awards from 30 million to 45 million shares.
OQB
ParkerVision's Q1 2025 results reveal a widened net loss primarily due to a non-cash charge, while the company continues to pursue patent enforcement actions and navigate rescheduled trial dates.
OQB
ParkerVision announces the resignation of a board member and salary increases for its CEO and CFO, along with an extension of their stock option expiration dates.
OQB
ParkerVision's 2024 results show a net loss of $14.5 million, but the company sees progress in patent litigation, including the revival of its case against Qualcomm.
OQB
ParkerVision has released the first episode of a four-part video series, 'Against the Giants,' to provide an in-depth look at its ongoing legal dispute with Qualcomm.
OQB
ParkerVision's Compensation Committee awarded one-time discretionary cash bonuses to CEO Jeffrey Parker ($350,000) and CFO Cynthia French ($100,000) in recognition of their contributions to strategic initiatives and financial stability.
OQB
ParkerVision, Inc. has entered into securities purchase agreements to raise $5 million through the sale of common stock and warrants to accredited investors.
OQB
ParkerVision, Inc. has appointed Frazier & Deeter, LLC as its new independent registered public accounting firm, effective December 17, 2024.
OQB
ParkerVision reported a net loss for the third quarter of 2024, but received a favorable court ruling in its patent infringement case against Qualcomm.
OQB
ParkerVision, Inc. is changing its independent auditor after MSL, P.A. merged with Forvis Mazars, LLP, and will cease services after completing the review of the September 30, 2024 quarterly report.
OQB
ParkerVision, Inc. has announced that its independent accounting firm, MSL, P.A., will cease services following a merger with Forvis Mazars, LLP, prompting a search for a new auditor.
OQB
ParkerVision Inc. successfully increased its authorized common stock shares from 175 million to 225 million after shareholder approval at its annual meeting.
OQB
The Court of Appeals for the Federal Circuit has reversed key rulings in the ParkerVision v. Qualcomm patent infringement case, sending it back to the District Court for trial.
OQB
ParkerVision reported a net loss for the second quarter of 2024 and is actively engaged in multiple patent infringement cases.
OQB
ParkerVision, Inc. has amended several convertible promissory notes, extending maturity dates and adjusting the conversion price for one note.
OQB
ParkerVision has amended three convertible promissory notes, extending their maturity dates to December 1, 2024.